# Effects of Enhancers and Inhibitors on Absorption From Iron Supplements

> **NCT05414474** · NA · COMPLETED · sponsor: **Swiss Federal Institute of Technology** · enrollment: 35 (actual)

## Conditions studied

- Iron-deficiency
- Iron Deficiency Anemia

## Interventions

- **OTHER:** Reference
- **OTHER:** Ascorbic acid (AA) 500 mg
- **OTHER:** Ascorbic acid (AA) 80 mg
- **OTHER:** Coffee
- **OTHER:** Breakfast
- **OTHER:** Afternoon

## Key facts

- **NCT ID:** NCT05414474
- **Lead sponsor:** Swiss Federal Institute of Technology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-20
- **Primary completion:** 2022-12-09
- **Final completion:** 2022-12-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414474, "Effects of Enhancers and Inhibitors on Absorption From Iron Supplements". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05414474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*